Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus is a research paper published in Open Forum Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01HL123336
National Institutes of Health
Grant: U01HL123339
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068636
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068634
ACTG Statistical and Data Management Center
Grant: UM1 AI106701
ACTG Laboratory Center
Grant: NIH P30DK 050561
NIAID NIH HHS
Grant: UM1 AI069452
NIAID NIH HHS
Grant: UM1 AI069456
NIDDK NIH HHS
Grant: R01 DK050561
NIDDK NIH HHS
Grant: R56 DK050561
NIDDK NIH HHS
Grant: P30 DK040561
NIAID NIH HHS
Grant: P30 AI050410
NIAID NIH HHS
Grant: P30 AI064518
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
Grant: 5U01HL123336-02
REPRIEVE - CCC - Lead Application
National Institutes of Health
Grant: 5U01HL123339-02
REPRIEVE - DCC
KOWA Pharmaceuticals
Gilead Sciences
ViiV Healthcare
FWCI
6.50
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals